nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—SLC22A1—hematologic cancer	0.231	0.775	CbGaD
Ranitidine—ABCB1—hematologic cancer	0.067	0.225	CbGaD
Ranitidine—SLC22A1—Cytarabine—hematologic cancer	0.019	0.0393	CbGbCtD
Ranitidine—CYP1A2—Anagrelide—hematologic cancer	0.0186	0.0384	CbGbCtD
Ranitidine—SLC22A1—Cladribine—hematologic cancer	0.018	0.0371	CbGbCtD
Ranitidine—SLC22A1—Imatinib—hematologic cancer	0.0165	0.0341	CbGbCtD
Ranitidine—SLC22A8—Mercaptopurine—hematologic cancer	0.0165	0.0341	CbGbCtD
Ranitidine—ABCB1—Lenalidomide—hematologic cancer	0.0113	0.0233	CbGbCtD
Ranitidine—CYP3A5—Daunorubicin—hematologic cancer	0.0102	0.021	CbGbCtD
Ranitidine—CYP2D6—Lomustine—hematologic cancer	0.00988	0.0204	CbGbCtD
Ranitidine—CYP1A2—Carmustine—hematologic cancer	0.00977	0.0202	CbGbCtD
Ranitidine—CYP3A5—Thalidomide—hematologic cancer	0.00925	0.0191	CbGbCtD
Ranitidine—CYP3A5—Teniposide—hematologic cancer	0.00883	0.0182	CbGbCtD
Ranitidine—CYP2D6—Idarubicin—hematologic cancer	0.00881	0.0182	CbGbCtD
Ranitidine—CYP2C19—Bortezomib—hematologic cancer	0.00857	0.0177	CbGbCtD
Ranitidine—CYP1A2—Methoxsalen—hematologic cancer	0.00831	0.0172	CbGbCtD
Ranitidine—CYP3A5—Ifosfamide—hematologic cancer	0.00815	0.0168	CbGbCtD
Ranitidine—CYP1A2—Bortezomib—hematologic cancer	0.00791	0.0163	CbGbCtD
Ranitidine—CYP3A5—Imatinib—hematologic cancer	0.00778	0.0161	CbGbCtD
Ranitidine—CYP1A2—Daunorubicin—hematologic cancer	0.00756	0.0156	CbGbCtD
Ranitidine—CYP2D6—Hydroxyurea—hematologic cancer	0.00749	0.0155	CbGbCtD
Ranitidine—CYP2C19—Thalidomide—hematologic cancer	0.00746	0.0154	CbGbCtD
Ranitidine—CYP1A2—Alitretinoin—hematologic cancer	0.00741	0.0153	CbGbCtD
Ranitidine—CYP2C19—Teniposide—hematologic cancer	0.00712	0.0147	CbGbCtD
Ranitidine—CYP1A2—Thalidomide—hematologic cancer	0.00689	0.0142	CbGbCtD
Ranitidine—CYP3A4—Bexarotene—hematologic cancer	0.00676	0.0139	CbGbCtD
Ranitidine—ABCB1—Daunorubicin—hematologic cancer	0.00661	0.0136	CbGbCtD
Ranitidine—CYP2C19—Ifosfamide—hematologic cancer	0.00657	0.0136	CbGbCtD
Ranitidine—CYP2D6—Bortezomib—hematologic cancer	0.00651	0.0134	CbGbCtD
Ranitidine—ABCB1—Alitretinoin—hematologic cancer	0.00648	0.0134	CbGbCtD
Ranitidine—CYP3A4—Lomustine—hematologic cancer	0.00628	0.013	CbGbCtD
Ranitidine—CYP3A4—Busulfan—hematologic cancer	0.00628	0.013	CbGbCtD
Ranitidine—CYP2C19—Imatinib—hematologic cancer	0.00628	0.013	CbGbCtD
Ranitidine—CYP3A5—Dasatinib—hematologic cancer	0.00625	0.0129	CbGbCtD
Ranitidine—CYP1A2—Dacarbazine—hematologic cancer	0.00592	0.0122	CbGbCtD
Ranitidine—CYP1A2—Imatinib—hematologic cancer	0.00579	0.012	CbGbCtD
Ranitidine—CYP3A4—Thiotepa—hematologic cancer	0.0056	0.0116	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—hematologic cancer	0.00539	0.0111	CbGbCtD
Ranitidine—ABCB1—Imatinib—hematologic cancer	0.00506	0.0105	CbGbCtD
Ranitidine—CYP3A5—Irinotecan—hematologic cancer	0.00486	0.01	CbGbCtD
Ranitidine—CYP2D6—Imatinib—hematologic cancer	0.00477	0.00985	CbGbCtD
Ranitidine—CYP1A2—Dasatinib—hematologic cancer	0.00465	0.0096	CbGbCtD
Ranitidine—ABCB1—Nilotinib—hematologic cancer	0.0046	0.0095	CbGbCtD
Ranitidine—ABCB1—Vinorelbine—hematologic cancer	0.00456	0.00942	CbGbCtD
Ranitidine—CYP3A4—Methoxsalen—hematologic cancer	0.00435	0.00899	CbGbCtD
Ranitidine—CYP2D6—Nilotinib—hematologic cancer	0.00434	0.00895	CbGbCtD
Ranitidine—CYP2D6—Vinorelbine—hematologic cancer	0.0043	0.00888	CbGbCtD
Ranitidine—CYP3A5—Vincristine—hematologic cancer	0.00425	0.00877	CbGbCtD
Ranitidine—CYP3A4—Bortezomib—hematologic cancer	0.00414	0.00855	CbGbCtD
Ranitidine—CYP2C19—Prednisone—hematologic cancer	0.00414	0.00854	CbGbCtD
Ranitidine—ABCB1—Dasatinib—hematologic cancer	0.00407	0.0084	CbGbCtD
Ranitidine—ABCB1—Mitoxantrone—hematologic cancer	0.00402	0.00829	CbGbCtD
Ranitidine—CYP3A4—Daunorubicin—hematologic cancer	0.00396	0.00818	CbGbCtD
Ranitidine—CYP3A5—Etoposide—hematologic cancer	0.00389	0.00804	CbGbCtD
Ranitidine—ABCB1—Betamethasone—hematologic cancer	0.00358	0.00739	CbGbCtD
Ranitidine—ABCB1—Gemcitabine—hematologic cancer	0.00355	0.00733	CbGbCtD
Ranitidine—ABCB1—Prednisolone—hematologic cancer	0.00353	0.00729	CbGbCtD
Ranitidine—CYP3A4—Cytarabine—hematologic cancer	0.00349	0.00721	CbGbCtD
Ranitidine—CYP3A4—Teniposide—hematologic cancer	0.00344	0.00711	CbGbCtD
Ranitidine—ABCB1—Prednisone—hematologic cancer	0.00334	0.00689	CbGbCtD
Ranitidine—CYP3A5—Dexamethasone—hematologic cancer	0.0032	0.00661	CbGbCtD
Ranitidine—CYP3A4—Ifosfamide—hematologic cancer	0.00318	0.00656	CbGbCtD
Ranitidine—ABCB1—Irinotecan—hematologic cancer	0.00316	0.00653	CbGbCtD
Ranitidine—CYP3A4—Imatinib—hematologic cancer	0.00303	0.00626	CbGbCtD
Ranitidine—CYP1A2—Etoposide—hematologic cancer	0.0029	0.00598	CbGbCtD
Ranitidine—CYP3A4—Ruxolitinib—hematologic cancer	0.00286	0.0059	CbGbCtD
Ranitidine—ABCB1—Vinblastine—hematologic cancer	0.00281	0.00581	CbGbCtD
Ranitidine—ABCB1—Vincristine—hematologic cancer	0.00277	0.00571	CbGbCtD
Ranitidine—CYP3A4—Nilotinib—hematologic cancer	0.00276	0.00569	CbGbCtD
Ranitidine—CYP3A4—Vinorelbine—hematologic cancer	0.00273	0.00564	CbGbCtD
Ranitidine—CYP2D6—Vinblastine—hematologic cancer	0.00265	0.00547	CbGbCtD
Ranitidine—CYP2C19—Dexamethasone—hematologic cancer	0.00258	0.00533	CbGbCtD
Ranitidine—ABCB1—Cisplatin—hematologic cancer	0.00258	0.00532	CbGbCtD
Ranitidine—ABCB1—Etoposide—hematologic cancer	0.00253	0.00523	CbGbCtD
Ranitidine—CYP3A4—Triamcinolone—hematologic cancer	0.0025	0.00516	CbGbCtD
Ranitidine—CYP3A4—Dasatinib—hematologic cancer	0.00244	0.00503	CbGbCtD
Ranitidine—CYP3A4—Mitoxantrone—hematologic cancer	0.00241	0.00497	CbGbCtD
Ranitidine—CYP3A4—Betamethasone—hematologic cancer	0.00215	0.00443	CbGbCtD
Ranitidine—CYP3A4—Prednisolone—hematologic cancer	0.00212	0.00437	CbGbCtD
Ranitidine—ABCB1—Dexamethasone—hematologic cancer	0.00208	0.0043	CbGbCtD
Ranitidine—CYP3A4—Prednisone—hematologic cancer	0.002	0.00413	CbGbCtD
Ranitidine—CYP2D6—Dexamethasone—hematologic cancer	0.00196	0.00405	CbGbCtD
Ranitidine—CYP3A4—Irinotecan—hematologic cancer	0.0019	0.00391	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—hematologic cancer	0.00173	0.00357	CbGbCtD
Ranitidine—CYP3A4—Vinblastine—hematologic cancer	0.00169	0.00348	CbGbCtD
Ranitidine—ABCB1—Methotrexate—hematologic cancer	0.00167	0.00346	CbGbCtD
Ranitidine—CYP3A4—Vincristine—hematologic cancer	0.00166	0.00342	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—hematologic cancer	0.00163	0.00336	CbGbCtD
Ranitidine—CYP3A4—Etoposide—hematologic cancer	0.00152	0.00313	CbGbCtD
Ranitidine—CYP3A4—Dexamethasone—hematologic cancer	0.00125	0.00258	CbGbCtD
Ranitidine—CYP3A4—Doxorubicin—hematologic cancer	0.00104	0.00214	CbGbCtD
Ranitidine—Nizatidine—ABCB1—hematologic cancer	0.000883	1	CrCbGaD
Ranitidine—HRH2—hematopoietic system—hematologic cancer	0.000737	0.114	CbGeAlD
Ranitidine—HRH2—blood—hematologic cancer	0.000489	0.0758	CbGeAlD
Ranitidine—SLC22A8—hematopoietic system—hematologic cancer	0.000437	0.0677	CbGeAlD
Ranitidine—HRH2—lung—hematologic cancer	0.000428	0.0664	CbGeAlD
Ranitidine—CYP2C19—hematopoietic system—hematologic cancer	0.000366	0.0568	CbGeAlD
Ranitidine—SLC22A1—blood—hematologic cancer	0.000315	0.0488	CbGeAlD
Ranitidine—CYP1A2—hematopoietic system—hematologic cancer	0.000299	0.0464	CbGeAlD
Ranitidine—HRH2—lymph node—hematologic cancer	0.000293	0.0454	CbGeAlD
Ranitidine—SLC22A8—blood—hematologic cancer	0.000289	0.0449	CbGeAlD
Ranitidine—CYP3A5—hematopoietic system—hematologic cancer	0.000288	0.0447	CbGeAlD
Ranitidine—CYP2C19—blood—hematologic cancer	0.000243	0.0376	CbGeAlD
Ranitidine—CYP3A4—hematopoietic system—hematologic cancer	0.000216	0.0336	CbGeAlD
Ranitidine—CYP2D6—hematopoietic system—hematologic cancer	0.000213	0.033	CbGeAlD
Ranitidine—CYP1A2—blood—hematologic cancer	0.000198	0.0307	CbGeAlD
Ranitidine—CYP3A5—blood—hematologic cancer	0.000191	0.0296	CbGeAlD
Ranitidine—CYP1A2—lung—hematologic cancer	0.000174	0.0269	CbGeAlD
Ranitidine—CYP3A5—lung—hematologic cancer	0.000168	0.026	CbGeAlD
Ranitidine—ABCB1—hematopoietic system—hematologic cancer	0.000153	0.0238	CbGeAlD
Ranitidine—CYP3A4—blood—hematologic cancer	0.000143	0.0222	CbGeAlD
Ranitidine—CYP2D6—blood—hematologic cancer	0.000141	0.0219	CbGeAlD
Ranitidine—CYP2D6—testis—hematologic cancer	0.000117	0.0181	CbGeAlD
Ranitidine—ABCB1—gonad—hematologic cancer	0.000116	0.0181	CbGeAlD
Ranitidine—ABCB1—blood—hematologic cancer	0.000102	0.0157	CbGeAlD
Ranitidine—ABCB1—bone marrow—hematologic cancer	9.82e-05	0.0152	CbGeAlD
Ranitidine—ABCB1—lung—hematologic cancer	8.9e-05	0.0138	CbGeAlD
Ranitidine—ABCB1—testis—hematologic cancer	8.4e-05	0.013	CbGeAlD
Ranitidine—ABCB1—lymph node—hematologic cancer	6.09e-05	0.00944	CbGeAlD
Ranitidine—Hypersensitivity—Cisplatin—hematologic cancer	2.99e-05	0.000172	CcSEcCtD
Ranitidine—Tachycardia—Dexamethasone—hematologic cancer	2.99e-05	0.000172	CcSEcCtD
Ranitidine—Tachycardia—Betamethasone—hematologic cancer	2.99e-05	0.000172	CcSEcCtD
Ranitidine—Bradycardia—Epirubicin—hematologic cancer	2.99e-05	0.000172	CcSEcCtD
Ranitidine—Headache—Alitretinoin—hematologic cancer	2.98e-05	0.000172	CcSEcCtD
Ranitidine—Angioedema—Prednisone—hematologic cancer	2.98e-05	0.000172	CcSEcCtD
Ranitidine—Diarrhoea—Gemcitabine—hematologic cancer	2.98e-05	0.000171	CcSEcCtD
Ranitidine—Nausea—Thalidomide—hematologic cancer	2.97e-05	0.000171	CcSEcCtD
Ranitidine—Rash—Ifosfamide—hematologic cancer	2.97e-05	0.000171	CcSEcCtD
Ranitidine—Dermatitis—Ifosfamide—hematologic cancer	2.97e-05	0.000171	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—hematologic cancer	2.96e-05	0.000171	CcSEcCtD
Ranitidine—Hyperhidrosis—Dexamethasone—hematologic cancer	2.96e-05	0.00017	CcSEcCtD
Ranitidine—Hyperhidrosis—Betamethasone—hematologic cancer	2.96e-05	0.00017	CcSEcCtD
Ranitidine—Dizziness—Irinotecan—hematologic cancer	2.96e-05	0.00017	CcSEcCtD
Ranitidine—Urticaria—Etoposide—hematologic cancer	2.95e-05	0.00017	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—hematologic cancer	2.95e-05	0.00017	CcSEcCtD
Ranitidine—Malaise—Prednisone—hematologic cancer	2.94e-05	0.000169	CcSEcCtD
Ranitidine—Body temperature increased—Etoposide—hematologic cancer	2.94e-05	0.000169	CcSEcCtD
Ranitidine—Abdominal pain—Etoposide—hematologic cancer	2.94e-05	0.000169	CcSEcCtD
Ranitidine—Vertigo—Prednisone—hematologic cancer	2.93e-05	0.000169	CcSEcCtD
Ranitidine—Hepatitis—Epirubicin—hematologic cancer	2.93e-05	0.000169	CcSEcCtD
Ranitidine—Vomiting—Vincristine—hematologic cancer	2.92e-05	0.000168	CcSEcCtD
Ranitidine—Urticaria—Prednisolone—hematologic cancer	2.91e-05	0.000168	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—hematologic cancer	2.9e-05	0.000167	CcSEcCtD
Ranitidine—Rash—Vincristine—hematologic cancer	2.89e-05	0.000167	CcSEcCtD
Ranitidine—Dermatitis—Vincristine—hematologic cancer	2.89e-05	0.000166	CcSEcCtD
Ranitidine—Pain—Triamcinolone—hematologic cancer	2.88e-05	0.000166	CcSEcCtD
Ranitidine—Headache—Vincristine—hematologic cancer	2.88e-05	0.000165	CcSEcCtD
Ranitidine—Hypotension—Betamethasone—hematologic cancer	2.86e-05	0.000165	CcSEcCtD
Ranitidine—Hypotension—Dexamethasone—hematologic cancer	2.86e-05	0.000165	CcSEcCtD
Ranitidine—Nausea—Carmustine—hematologic cancer	2.86e-05	0.000164	CcSEcCtD
Ranitidine—Vomiting—Mitoxantrone—hematologic cancer	2.84e-05	0.000164	CcSEcCtD
Ranitidine—Vomiting—Irinotecan—hematologic cancer	2.84e-05	0.000164	CcSEcCtD
Ranitidine—Nausea—Alitretinoin—hematologic cancer	2.83e-05	0.000163	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—hematologic cancer	2.82e-05	0.000162	CcSEcCtD
Ranitidine—Rash—Mitoxantrone—hematologic cancer	2.82e-05	0.000162	CcSEcCtD
Ranitidine—Rash—Irinotecan—hematologic cancer	2.82e-05	0.000162	CcSEcCtD
Ranitidine—Dermatitis—Mitoxantrone—hematologic cancer	2.82e-05	0.000162	CcSEcCtD
Ranitidine—Dermatitis—Irinotecan—hematologic cancer	2.82e-05	0.000162	CcSEcCtD
Ranitidine—Headache—Irinotecan—hematologic cancer	2.8e-05	0.000161	CcSEcCtD
Ranitidine—Headache—Mitoxantrone—hematologic cancer	2.8e-05	0.000161	CcSEcCtD
Ranitidine—Nausea—Ifosfamide—hematologic cancer	2.8e-05	0.000161	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.79e-05	0.00016	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.79e-05	0.00016	CcSEcCtD
Ranitidine—Myalgia—Prednisone—hematologic cancer	2.78e-05	0.00016	CcSEcCtD
Ranitidine—Arthralgia—Prednisone—hematologic cancer	2.78e-05	0.00016	CcSEcCtD
Ranitidine—Feeling abnormal—Triamcinolone—hematologic cancer	2.78e-05	0.00016	CcSEcCtD
Ranitidine—Diarrhoea—Cisplatin—hematologic cancer	2.78e-05	0.00016	CcSEcCtD
Ranitidine—Erythema multiforme—Epirubicin—hematologic cancer	2.77e-05	0.00016	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—hematologic cancer	2.77e-05	0.000159	CcSEcCtD
Ranitidine—Vomiting—Gemcitabine—hematologic cancer	2.77e-05	0.000159	CcSEcCtD
Ranitidine—Insomnia—Betamethasone—hematologic cancer	2.77e-05	0.000159	CcSEcCtD
Ranitidine—Insomnia—Dexamethasone—hematologic cancer	2.77e-05	0.000159	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—hematologic cancer	2.76e-05	0.000159	CcSEcCtD
Ranitidine—Discomfort—Prednisone—hematologic cancer	2.75e-05	0.000158	CcSEcCtD
Ranitidine—Rash—Gemcitabine—hematologic cancer	2.75e-05	0.000158	CcSEcCtD
Ranitidine—Dermatitis—Gemcitabine—hematologic cancer	2.74e-05	0.000158	CcSEcCtD
Ranitidine—Hypersensitivity—Etoposide—hematologic cancer	2.74e-05	0.000158	CcSEcCtD
Ranitidine—Erythema—Methotrexate—hematologic cancer	2.73e-05	0.000157	CcSEcCtD
Ranitidine—Headache—Gemcitabine—hematologic cancer	2.73e-05	0.000157	CcSEcCtD
Ranitidine—Nausea—Vincristine—hematologic cancer	2.73e-05	0.000157	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—hematologic cancer	2.71e-05	0.000156	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisolone—hematologic cancer	2.7e-05	0.000155	CcSEcCtD
Ranitidine—Urticaria—Triamcinolone—hematologic cancer	2.68e-05	0.000154	CcSEcCtD
Ranitidine—Body temperature increased—Triamcinolone—hematologic cancer	2.67e-05	0.000153	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisone—hematologic cancer	2.67e-05	0.000153	CcSEcCtD
Ranitidine—Nausea—Mitoxantrone—hematologic cancer	2.66e-05	0.000153	CcSEcCtD
Ranitidine—Nausea—Irinotecan—hematologic cancer	2.66e-05	0.000153	CcSEcCtD
Ranitidine—Pruritus—Etoposide—hematologic cancer	2.63e-05	0.000151	CcSEcCtD
Ranitidine—Arrhythmia—Epirubicin—hematologic cancer	2.62e-05	0.000151	CcSEcCtD
Ranitidine—Pain—Betamethasone—hematologic cancer	2.62e-05	0.000151	CcSEcCtD
Ranitidine—Pain—Dexamethasone—hematologic cancer	2.62e-05	0.000151	CcSEcCtD
Ranitidine—Tachycardia—Prednisone—hematologic cancer	2.6e-05	0.00015	CcSEcCtD
Ranitidine—Alopecia—Epirubicin—hematologic cancer	2.59e-05	0.000149	CcSEcCtD
Ranitidine—Nausea—Gemcitabine—hematologic cancer	2.59e-05	0.000149	CcSEcCtD
Ranitidine—Vomiting—Cisplatin—hematologic cancer	2.58e-05	0.000148	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisone—hematologic cancer	2.58e-05	0.000148	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—hematologic cancer	2.57e-05	0.000148	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—hematologic cancer	2.57e-05	0.000148	CcSEcCtD
Ranitidine—Rash—Cisplatin—hematologic cancer	2.56e-05	0.000147	CcSEcCtD
Ranitidine—Dermatitis—Cisplatin—hematologic cancer	2.56e-05	0.000147	CcSEcCtD
Ranitidine—Erythema—Epirubicin—hematologic cancer	2.55e-05	0.000147	CcSEcCtD
Ranitidine—Diarrhoea—Etoposide—hematologic cancer	2.54e-05	0.000146	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—hematologic cancer	2.53e-05	0.000146	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—hematologic cancer	2.52e-05	0.000145	CcSEcCtD
Ranitidine—Feeling abnormal—Dexamethasone—hematologic cancer	2.52e-05	0.000145	CcSEcCtD
Ranitidine—Feeling abnormal—Betamethasone—hematologic cancer	2.52e-05	0.000145	CcSEcCtD
Ranitidine—Hypersensitivity—Triamcinolone—hematologic cancer	2.48e-05	0.000143	CcSEcCtD
Ranitidine—Malaise—Methotrexate—hematologic cancer	2.46e-05	0.000142	CcSEcCtD
Ranitidine—Dizziness—Etoposide—hematologic cancer	2.46e-05	0.000141	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—hematologic cancer	2.45e-05	0.000141	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—hematologic cancer	2.44e-05	0.000141	CcSEcCtD
Ranitidine—Urticaria—Betamethasone—hematologic cancer	2.43e-05	0.00014	CcSEcCtD
Ranitidine—Urticaria—Dexamethasone—hematologic cancer	2.43e-05	0.00014	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.43e-05	0.00014	CcSEcCtD
Ranitidine—Dizziness—Prednisolone—hematologic cancer	2.43e-05	0.00014	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—hematologic cancer	2.42e-05	0.00014	CcSEcCtD
Ranitidine—Abdominal pain—Betamethasone—hematologic cancer	2.42e-05	0.000139	CcSEcCtD
Ranitidine—Abdominal pain—Dexamethasone—hematologic cancer	2.42e-05	0.000139	CcSEcCtD
Ranitidine—Body temperature increased—Betamethasone—hematologic cancer	2.42e-05	0.000139	CcSEcCtD
Ranitidine—Body temperature increased—Dexamethasone—hematologic cancer	2.42e-05	0.000139	CcSEcCtD
Ranitidine—Nausea—Cisplatin—hematologic cancer	2.41e-05	0.000139	CcSEcCtD
Ranitidine—Insomnia—Prednisone—hematologic cancer	2.41e-05	0.000139	CcSEcCtD
Ranitidine—Vision blurred—Epirubicin—hematologic cancer	2.41e-05	0.000138	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—hematologic cancer	2.4e-05	0.000138	CcSEcCtD
Ranitidine—Pruritus—Triamcinolone—hematologic cancer	2.39e-05	0.000137	CcSEcCtD
Ranitidine—Ill-defined disorder—Epirubicin—hematologic cancer	2.37e-05	0.000136	CcSEcCtD
Ranitidine—Vomiting—Etoposide—hematologic cancer	2.36e-05	0.000136	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—hematologic cancer	2.36e-05	0.000136	CcSEcCtD
Ranitidine—Anaemia—Epirubicin—hematologic cancer	2.36e-05	0.000136	CcSEcCtD
Ranitidine—Agitation—Epirubicin—hematologic cancer	2.35e-05	0.000135	CcSEcCtD
Ranitidine—Rash—Etoposide—hematologic cancer	2.34e-05	0.000135	CcSEcCtD
Ranitidine—Dermatitis—Etoposide—hematologic cancer	2.34e-05	0.000135	CcSEcCtD
Ranitidine—Headache—Etoposide—hematologic cancer	2.33e-05	0.000134	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—hematologic cancer	2.32e-05	0.000134	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—hematologic cancer	2.32e-05	0.000134	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—hematologic cancer	2.32e-05	0.000134	CcSEcCtD
Ranitidine—Rash—Prednisolone—hematologic cancer	2.31e-05	0.000133	CcSEcCtD
Ranitidine—Dermatitis—Prednisolone—hematologic cancer	2.31e-05	0.000133	CcSEcCtD
Ranitidine—Malaise—Epirubicin—hematologic cancer	2.3e-05	0.000133	CcSEcCtD
Ranitidine—Headache—Prednisolone—hematologic cancer	2.3e-05	0.000132	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—hematologic cancer	2.3e-05	0.000132	CcSEcCtD
Ranitidine—Vertigo—Epirubicin—hematologic cancer	2.29e-05	0.000132	CcSEcCtD
Ranitidine—Leukopenia—Epirubicin—hematologic cancer	2.29e-05	0.000132	CcSEcCtD
Ranitidine—Constipation—Prednisone—hematologic cancer	2.28e-05	0.000131	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—hematologic cancer	2.25e-05	0.000129	CcSEcCtD
Ranitidine—Dizziness—Triamcinolone—hematologic cancer	2.23e-05	0.000128	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—hematologic cancer	2.23e-05	0.000128	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—hematologic cancer	2.23e-05	0.000128	CcSEcCtD
Ranitidine—Nausea—Etoposide—hematologic cancer	2.21e-05	0.000127	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisone—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.19e-05	0.000126	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—hematologic cancer	2.18e-05	0.000126	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Ranitidine—Nausea—Prednisolone—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Ranitidine—Chest pain—Epirubicin—hematologic cancer	2.17e-05	0.000125	CcSEcCtD
Ranitidine—Myalgia—Epirubicin—hematologic cancer	2.17e-05	0.000125	CcSEcCtD
Ranitidine—Arthralgia—Epirubicin—hematologic cancer	2.17e-05	0.000125	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—hematologic cancer	2.17e-05	0.000125	CcSEcCtD
Ranitidine—Pruritus—Betamethasone—hematologic cancer	2.17e-05	0.000125	CcSEcCtD
Ranitidine—Pruritus—Dexamethasone—hematologic cancer	2.17e-05	0.000125	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—hematologic cancer	2.15e-05	0.000124	CcSEcCtD
Ranitidine—Discomfort—Epirubicin—hematologic cancer	2.15e-05	0.000124	CcSEcCtD
Ranitidine—Vomiting—Triamcinolone—hematologic cancer	2.14e-05	0.000123	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—hematologic cancer	2.13e-05	0.000123	CcSEcCtD
Ranitidine—Rash—Triamcinolone—hematologic cancer	2.13e-05	0.000122	CcSEcCtD
Ranitidine—Dermatitis—Triamcinolone—hematologic cancer	2.12e-05	0.000122	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—hematologic cancer	2.12e-05	0.000122	CcSEcCtD
Ranitidine—Urticaria—Prednisone—hematologic cancer	2.12e-05	0.000122	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—hematologic cancer	2.12e-05	0.000122	CcSEcCtD
Ranitidine—Headache—Triamcinolone—hematologic cancer	2.11e-05	0.000122	CcSEcCtD
Ranitidine—Body temperature increased—Prednisone—hematologic cancer	2.11e-05	0.000121	CcSEcCtD
Ranitidine—Abdominal pain—Prednisone—hematologic cancer	2.11e-05	0.000121	CcSEcCtD
Ranitidine—Confusional state—Epirubicin—hematologic cancer	2.1e-05	0.000121	CcSEcCtD
Ranitidine—Diarrhoea—Dexamethasone—hematologic cancer	2.09e-05	0.00012	CcSEcCtD
Ranitidine—Diarrhoea—Betamethasone—hematologic cancer	2.09e-05	0.00012	CcSEcCtD
Ranitidine—Anaphylactic shock—Epirubicin—hematologic cancer	2.08e-05	0.00012	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—hematologic cancer	2.08e-05	0.00012	CcSEcCtD
Ranitidine—Thrombocytopenia—Epirubicin—hematologic cancer	2.04e-05	0.000117	CcSEcCtD
Ranitidine—Tachycardia—Epirubicin—hematologic cancer	2.03e-05	0.000117	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.03e-05	0.000117	CcSEcCtD
Ranitidine—Dizziness—Dexamethasone—hematologic cancer	2.02e-05	0.000116	CcSEcCtD
Ranitidine—Dizziness—Betamethasone—hematologic cancer	2.02e-05	0.000116	CcSEcCtD
Ranitidine—Hyperhidrosis—Epirubicin—hematologic cancer	2.01e-05	0.000116	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—hematologic cancer	2.01e-05	0.000116	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—hematologic cancer	2.01e-05	0.000116	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—hematologic cancer	2.01e-05	0.000116	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—hematologic cancer	2.01e-05	0.000116	CcSEcCtD
Ranitidine—Nausea—Triamcinolone—hematologic cancer	2e-05	0.000115	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—hematologic cancer	1.99e-05	0.000114	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—hematologic cancer	1.99e-05	0.000114	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—hematologic cancer	1.98e-05	0.000114	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisone—hematologic cancer	1.96e-05	0.000113	CcSEcCtD
Ranitidine—Hypotension—Epirubicin—hematologic cancer	1.95e-05	0.000112	CcSEcCtD
Ranitidine—Vomiting—Betamethasone—hematologic cancer	1.95e-05	0.000112	CcSEcCtD
Ranitidine—Vomiting—Dexamethasone—hematologic cancer	1.95e-05	0.000112	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—hematologic cancer	1.94e-05	0.000112	CcSEcCtD
Ranitidine—Rash—Dexamethasone—hematologic cancer	1.93e-05	0.000111	CcSEcCtD
Ranitidine—Rash—Betamethasone—hematologic cancer	1.93e-05	0.000111	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.93e-05	0.000111	CcSEcCtD
Ranitidine—Dermatitis—Betamethasone—hematologic cancer	1.93e-05	0.000111	CcSEcCtD
Ranitidine—Dermatitis—Dexamethasone—hematologic cancer	1.93e-05	0.000111	CcSEcCtD
Ranitidine—Headache—Dexamethasone—hematologic cancer	1.92e-05	0.00011	CcSEcCtD
Ranitidine—Headache—Betamethasone—hematologic cancer	1.92e-05	0.00011	CcSEcCtD
Ranitidine—Pain—Methotrexate—hematologic cancer	1.9e-05	0.00011	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.9e-05	0.000109	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.89e-05	0.000109	CcSEcCtD
Ranitidine—Pruritus—Prednisone—hematologic cancer	1.89e-05	0.000108	CcSEcCtD
Ranitidine—Insomnia—Epirubicin—hematologic cancer	1.89e-05	0.000108	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—hematologic cancer	1.88e-05	0.000108	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.86e-05	0.000107	CcSEcCtD
Ranitidine—Dyspnoea—Epirubicin—hematologic cancer	1.86e-05	0.000107	CcSEcCtD
Ranitidine—Somnolence—Epirubicin—hematologic cancer	1.85e-05	0.000107	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—hematologic cancer	1.84e-05	0.000106	CcSEcCtD
Ranitidine—Diarrhoea—Prednisone—hematologic cancer	1.82e-05	0.000105	CcSEcCtD
Ranitidine—Nausea—Betamethasone—hematologic cancer	1.82e-05	0.000105	CcSEcCtD
Ranitidine—Nausea—Dexamethasone—hematologic cancer	1.82e-05	0.000105	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—hematologic cancer	1.8e-05	0.000104	CcSEcCtD
Ranitidine—Constipation—Epirubicin—hematologic cancer	1.78e-05	0.000103	CcSEcCtD
Ranitidine—Pain—Epirubicin—hematologic cancer	1.78e-05	0.000103	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—hematologic cancer	1.77e-05	0.000102	CcSEcCtD
Ranitidine—Dizziness—Prednisone—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—hematologic cancer	1.74e-05	0.0001	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—hematologic cancer	1.72e-05	9.89e-05	CcSEcCtD
Ranitidine—Feeling abnormal—Epirubicin—hematologic cancer	1.72e-05	9.88e-05	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—hematologic cancer	1.71e-05	9.86e-05	CcSEcCtD
Ranitidine—Vomiting—Prednisone—hematologic cancer	1.69e-05	9.75e-05	CcSEcCtD
Ranitidine—Rash—Prednisone—hematologic cancer	1.68e-05	9.67e-05	CcSEcCtD
Ranitidine—Dermatitis—Prednisone—hematologic cancer	1.68e-05	9.66e-05	CcSEcCtD
Ranitidine—Headache—Prednisone—hematologic cancer	1.67e-05	9.61e-05	CcSEcCtD
Ranitidine—Urticaria—Epirubicin—hematologic cancer	1.66e-05	9.53e-05	CcSEcCtD
Ranitidine—Pain—Doxorubicin—hematologic cancer	1.65e-05	9.49e-05	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—hematologic cancer	1.65e-05	9.49e-05	CcSEcCtD
Ranitidine—Body temperature increased—Epirubicin—hematologic cancer	1.65e-05	9.48e-05	CcSEcCtD
Ranitidine—Abdominal pain—Epirubicin—hematologic cancer	1.65e-05	9.48e-05	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—hematologic cancer	1.64e-05	9.44e-05	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—hematologic cancer	1.59e-05	9.14e-05	CcSEcCtD
Ranitidine—Nausea—Prednisone—hematologic cancer	1.58e-05	9.11e-05	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—hematologic cancer	1.58e-05	9.07e-05	CcSEcCtD
Ranitidine—Hypersensitivity—Epirubicin—hematologic cancer	1.54e-05	8.84e-05	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—hematologic cancer	1.53e-05	8.82e-05	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—hematologic cancer	1.52e-05	8.77e-05	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—hematologic cancer	1.52e-05	8.77e-05	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—hematologic cancer	1.52e-05	8.77e-05	CcSEcCtD
Ranitidine—Pruritus—Epirubicin—hematologic cancer	1.47e-05	8.48e-05	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—hematologic cancer	1.47e-05	8.47e-05	CcSEcCtD
Ranitidine—Diarrhoea—Epirubicin—hematologic cancer	1.43e-05	8.21e-05	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—hematologic cancer	1.42e-05	8.18e-05	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—hematologic cancer	1.42e-05	8.15e-05	CcSEcCtD
Ranitidine—Rash—Methotrexate—hematologic cancer	1.4e-05	8.08e-05	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—hematologic cancer	1.4e-05	8.07e-05	CcSEcCtD
Ranitidine—Headache—Methotrexate—hematologic cancer	1.4e-05	8.03e-05	CcSEcCtD
Ranitidine—Dizziness—Epirubicin—hematologic cancer	1.38e-05	7.93e-05	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—hematologic cancer	1.36e-05	7.85e-05	CcSEcCtD
Ranitidine—Vomiting—Epirubicin—hematologic cancer	1.33e-05	7.62e-05	CcSEcCtD
Ranitidine—Nausea—Methotrexate—hematologic cancer	1.32e-05	7.61e-05	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—hematologic cancer	1.32e-05	7.59e-05	CcSEcCtD
Ranitidine—Rash—Epirubicin—hematologic cancer	1.31e-05	7.56e-05	CcSEcCtD
Ranitidine—Dermatitis—Epirubicin—hematologic cancer	1.31e-05	7.55e-05	CcSEcCtD
Ranitidine—Headache—Epirubicin—hematologic cancer	1.31e-05	7.51e-05	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—hematologic cancer	1.28e-05	7.34e-05	CcSEcCtD
Ranitidine—Nausea—Epirubicin—hematologic cancer	1.24e-05	7.12e-05	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—hematologic cancer	1.23e-05	7.06e-05	CcSEcCtD
Ranitidine—Rash—Doxorubicin—hematologic cancer	1.22e-05	7e-05	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—hematologic cancer	1.21e-05	6.99e-05	CcSEcCtD
Ranitidine—Headache—Doxorubicin—hematologic cancer	1.21e-05	6.95e-05	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—hematologic cancer	1.15e-05	6.59e-05	CcSEcCtD
Ranitidine—HRH2—Signaling by GPCR—KRAS—hematologic cancer	4.65e-06	0.000126	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CD44—hematologic cancer	4.64e-06	0.000126	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NQO1—hematologic cancer	4.64e-06	0.000126	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NUP214—hematologic cancer	4.63e-06	0.000126	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.61e-06	0.000125	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.58e-06	0.000125	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NCOR1—hematologic cancer	4.58e-06	0.000124	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTM1—hematologic cancer	4.58e-06	0.000124	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALOX5—hematologic cancer	4.56e-06	0.000124	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ADCY7—hematologic cancer	4.55e-06	0.000124	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NCOA3—hematologic cancer	4.55e-06	0.000124	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FGF2—hematologic cancer	4.55e-06	0.000124	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.54e-06	0.000123	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MTR—hematologic cancer	4.54e-06	0.000123	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NUP214—hematologic cancer	4.52e-06	0.000123	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3R1—hematologic cancer	4.48e-06	0.000122	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ENO2—hematologic cancer	4.45e-06	0.000121	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MTR—hematologic cancer	4.43e-06	0.00012	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ABCG2—hematologic cancer	4.43e-06	0.00012	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NUP98—hematologic cancer	4.42e-06	0.00012	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYCS—hematologic cancer	4.39e-06	0.000119	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—IDH1—hematologic cancer	4.39e-06	0.000119	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.36e-06	0.000119	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—JAK2—hematologic cancer	4.36e-06	0.000118	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ENO2—hematologic cancer	4.34e-06	0.000118	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.34e-06	0.000118	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TXN—hematologic cancer	4.34e-06	0.000118	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.34e-06	0.000118	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.32e-06	0.000117	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.29e-06	0.000117	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.29e-06	0.000117	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CA—hematologic cancer	4.27e-06	0.000116	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NUP214—hematologic cancer	4.26e-06	0.000116	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MDM2—hematologic cancer	4.25e-06	0.000116	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.25e-06	0.000115	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.25e-06	0.000115	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—FHL2—hematologic cancer	4.24e-06	0.000115	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—SDC1—hematologic cancer	4.22e-06	0.000115	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTT1—hematologic cancer	4.21e-06	0.000114	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.17e-06	0.000113	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MTR—hematologic cancer	4.17e-06	0.000113	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AGRN—hematologic cancer	4.15e-06	0.000113	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MTOR—hematologic cancer	4.14e-06	0.000112	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CB—hematologic cancer	4.14e-06	0.000112	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SDC1—hematologic cancer	4.12e-06	0.000112	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ENO2—hematologic cancer	4.09e-06	0.000111	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.09e-06	0.000111	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.08e-06	0.000111	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—MTHFR—hematologic cancer	4.05e-06	0.00011	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.03e-06	0.00011	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.98e-06	0.000108	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.97e-06	0.000108	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.97e-06	0.000108	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.97e-06	0.000108	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—HRAS—hematologic cancer	3.95e-06	0.000107	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.95e-06	0.000107	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.94e-06	0.000107	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.94e-06	0.000107	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN1B—hematologic cancer	3.88e-06	0.000106	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SDC1—hematologic cancer	3.88e-06	0.000105	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.87e-06	0.000105	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.87e-06	0.000105	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AKT1—hematologic cancer	3.84e-06	0.000104	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CASP3—hematologic cancer	3.81e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.81e-06	0.000103	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2—hematologic cancer	3.8e-06	0.000103	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL6—hematologic cancer	3.78e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NUP98—hematologic cancer	3.74e-06	0.000102	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCND1—hematologic cancer	3.71e-06	0.000101	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.7e-06	0.000101	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—JUN—hematologic cancer	3.7e-06	0.0001	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.69e-06	0.0001	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.66e-06	9.95e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.64e-06	9.88e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.64e-06	9.88e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NUP214—hematologic cancer	3.61e-06	9.81e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CA9—hematologic cancer	3.6e-06	9.78e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.6e-06	9.78e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CD44—hematologic cancer	3.59e-06	9.75e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NQO1—hematologic cancer	3.59e-06	9.75e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN1A—hematologic cancer	3.58e-06	9.74e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTEN—hematologic cancer	3.58e-06	9.72e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.57e-06	9.71e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.56e-06	9.66e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.56e-06	9.66e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.55e-06	9.66e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTR—hematologic cancer	3.54e-06	9.61e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.54e-06	9.61e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.51e-06	9.54e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CD44—hematologic cancer	3.5e-06	9.51e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NQO1—hematologic cancer	3.5e-06	9.51e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK8—hematologic cancer	3.5e-06	9.5e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT1—hematologic cancer	3.49e-06	9.48e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ENO2—hematologic cancer	3.47e-06	9.42e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EP300—hematologic cancer	3.41e-06	9.27e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CG—hematologic cancer	3.4e-06	9.24e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYCS—hematologic cancer	3.39e-06	9.22e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.39e-06	9.2e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.37e-06	9.16e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.36e-06	9.14e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.35e-06	9.1e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.35e-06	9.1e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TXN—hematologic cancer	3.35e-06	9.1e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SRC—hematologic cancer	3.32e-06	9.01e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYCS—hematologic cancer	3.31e-06	9e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.31e-06	9e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.3e-06	8.97e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CD44—hematologic cancer	3.3e-06	8.97e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.29e-06	8.94e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.29e-06	8.93e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.28e-06	8.9e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—hematologic cancer	3.23e-06	8.78e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—hematologic cancer	3.2e-06	8.69e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NRAS—hematologic cancer	3.19e-06	8.67e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CREBBP—hematologic cancer	3.15e-06	8.56e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.15e-06	8.55e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.14e-06	8.54e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.14e-06	8.53e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.12e-06	8.48e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.1e-06	8.43e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.1e-06	8.42e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.06e-06	8.32e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.06e-06	8.32e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK3—hematologic cancer	3.06e-06	8.3e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.04e-06	8.25e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.99e-06	8.13e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CD—hematologic cancer	2.99e-06	8.12e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.98e-06	8.11e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—hematologic cancer	2.97e-06	8.07e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.97e-06	8.06e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TGFB1—hematologic cancer	2.96e-06	8.05e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ALB—hematologic cancer	2.95e-06	8.02e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTP1—hematologic cancer	2.92e-06	7.93e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.9e-06	7.87e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.89e-06	7.85e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.83e-06	7.7e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.82e-06	7.67e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.81e-06	7.62e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.81e-06	7.62e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CD44—hematologic cancer	2.8e-06	7.59e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NQO1—hematologic cancer	2.8e-06	7.59e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.79e-06	7.57e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.75e-06	7.48e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.75e-06	7.47e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.75e-06	7.47e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KRAS—hematologic cancer	2.75e-06	7.46e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.74e-06	7.44e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.73e-06	7.41e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTR—hematologic cancer	2.73e-06	7.41e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.68e-06	7.29e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.68e-06	7.29e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.68e-06	7.27e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.65e-06	7.19e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.64e-06	7.18e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.63e-06	7.14e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	2.61e-06	7.08e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.61e-06	7.08e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.6e-06	7.05e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.54e-06	6.89e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.53e-06	6.87e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.53e-06	6.87e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CA—hematologic cancer	2.52e-06	6.85e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.45e-06	6.65e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—hematologic cancer	2.44e-06	6.63e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.43e-06	6.6e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MTHFR—hematologic cancer	2.37e-06	6.44e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.37e-06	6.43e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HRAS—hematologic cancer	2.33e-06	6.34e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.33e-06	6.33e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.32e-06	6.31e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ALB—hematologic cancer	2.29e-06	6.23e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.26e-06	6.13e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—hematologic cancer	2.25e-06	6.12e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.24e-06	6.07e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—hematologic cancer	2.23e-06	6.07e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.21e-06	6e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.19e-06	5.96e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.16e-06	5.86e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CD44—hematologic cancer	2.16e-06	5.86e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—EP300—hematologic cancer	2.15e-06	5.83e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.14e-06	5.82e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.14e-06	5.82e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.14e-06	5.82e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT1—hematologic cancer	2.06e-06	5.6e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.04e-06	5.55e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.04e-06	5.55e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.03e-06	5.51e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.02e-06	5.5e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.99e-06	5.41e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.89e-06	5.14e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.89e-06	5.14e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.88e-06	5.1e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.85e-06	5.02e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.8e-06	4.89e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.8e-06	4.88e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ALB—hematologic cancer	1.77e-06	4.81e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.75e-06	4.76e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—hematologic cancer	1.75e-06	4.75e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.74e-06	4.73e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ALB—hematologic cancer	1.73e-06	4.7e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.7e-06	4.63e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.7e-06	4.6e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.67e-06	4.53e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—EP300—hematologic cancer	1.67e-06	4.53e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.65e-06	4.49e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.65e-06	4.49e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.65e-06	4.49e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.65e-06	4.49e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALB—hematologic cancer	1.63e-06	4.43e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.59e-06	4.32e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.59e-06	4.31e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.56e-06	4.25e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.56e-06	4.24e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.53e-06	4.15e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.48e-06	4.01e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.46e-06	3.97e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.44e-06	3.91e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.4e-06	3.8e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALB—hematologic cancer	1.38e-06	3.75e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.35e-06	3.67e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.32e-06	3.59e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—hematologic cancer	1.32e-06	3.58e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AKT1—hematologic cancer	1.3e-06	3.52e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—EP300—hematologic cancer	1.29e-06	3.5e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—EP300—hematologic cancer	1.26e-06	3.42e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.24e-06	3.38e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.23e-06	3.35e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.23e-06	3.34e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.22e-06	3.31e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—EP300—hematologic cancer	1.19e-06	3.22e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.14e-06	3.09e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.08e-06	2.93e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALB—hematologic cancer	1.07e-06	2.89e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.05e-06	2.86e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.02e-06	2.77e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.01e-06	2.74e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—EP300—hematologic cancer	1e-06	2.73e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.54e-07	2.59e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.41e-07	2.56e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.31e-07	2.53e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.77e-07	2.38e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—hematologic cancer	8.13e-07	2.21e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AKT1—hematologic cancer	7.79e-07	2.12e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—EP300—hematologic cancer	7.75e-07	2.11e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AKT1—hematologic cancer	7.61e-07	2.07e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.43e-07	2.02e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AKT1—hematologic cancer	7.17e-07	1.95e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKT1—hematologic cancer	6.07e-07	1.65e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.74e-07	1.56e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.69e-07	1.27e-05	CbGpPWpGaD
